Sequential ventilation/perfusion imaging of massive pulmonary embolism treated with recombinant tissue plasminogen activator.
Pulmonary embolism is a common clinical problem estimated to cause 200,000 deaths per year in the United State. There is increasing interest in early diagnosis and prompt aggressive therapy. A case is reported of a patient with massive pulmonary embolism treated with recombinant tissue plasminogen activator. Ventilation/perfusion imaging was used both to make an early diagnosis as well as to evaluate the efficacy of therapy.
Petronis
J
J
Division of Nuclear Medicine, Francis Scott Key Medical Center, Baltimore, Maryland 21224.
D000328:Adult; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging*; D008297:Male; D011655:Pulmonary Embolism / Q000000981:diagnostic imaging* / Q000188:drug therapy; D011877:Radionuclide Imaging; D011994:Recombinant Proteins / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014692:Ventilation-Perfusion Ratio
D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator